Picture of Zelira Therapeutics logo

ZLD — Zelira Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: Zelira Therapeutics Says HY Net Loss Attributable A$34.1 Million Versus Loss A$3.3 Million

Feb 22 (Reuters) - Zelira Therapeutics Ltd  ZLD.AX :
    * HY NET LOSS ATTRIBUTABLE A$34.1 MILLION  VERSUS LOSS A$3.3
MILLION

Source text for Eikon:  ID:nASX4wPxVF 
Further company coverage:  ZLD.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zelira Therapeutics

See all news